Examination of intraoperative use of tranexamic acid in patients undergoing radical hysterectomy
Not Applicable
- Conditions
- uterine cancer
- Registration Number
- JPRN-UMIN000009226
- Lead Sponsor
- Tokyo Metropolitan Tama Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria are atrial fibrillation,coronary artery disease treated with drug eluting stent,severe chronic renal failure,congenital or acquired thrombophilia,and known or suspected allergy to tranexamic acid.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intraoperative blood loss
- Secondary Outcome Measures
Name Time Method the rate of intraoperative transfusion,perioperative complication rate